Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Opko Health stock falls 10% after drug approval faces delay
Opko Health stock falls 10% after drug approval faces delay
Opko Health stock falls 10% after drug approval faces delay
Submitted by
admin
on March 30, 2016 - 9:21pm
Source:
Bizjournals.com
News Tags:
FDA
OPKO Health
Rayaldee
kidney disease
Headline:
Opko Health stock falls 10% after drug approval faces delay
Do Not Allow Advertisers to Use My Personal information
